The American Cancer Society announces the establishment of the Harry and Elsa Jiler American Cancer Society Clinical Research Professorship and invites interested candidates to submit proposals.
This prestigious grant is intended for an outstanding clinician-scientist in mid-career who has made significant contributions in cancer research and is considered an exceptional leader in his/her field. Applicants may be active in any area of clinical or epidemiologic cancer research, including cancer control, clinical trials directed toward new therapeutic approaches, psychosocial and behavioral, health services, and health policy research. Translational laboratory research that has clinical application is also appropriate.
Candidates must be US citizens or permanent residents with at least 10 years of experience beyond receipt of the MD or other doctoral degree. Individuals employed by for-profit organizations, federal agencies, or agencies supported entirely by the federal government are not eligible. At the time of the application, the candidate must have a full-time academic or comparable appointment. Generally, candidates must have obtained the rank of associate or full professor or the equivalent; however, they must not have held the rank of full professor or equivalent for more than 15 years.
The Harry and Elsa Jiler American Cancer Society Clinical Research Professor will be chosen by a peer review process emphasizing past contributions and future potential, but most importantly, innovation in the field and the ability to attract young investigators into cancer research. The grant provides up to $60,000 annually that can be apportioned to salary and/or research project support at the discretion of the awardee. The Professorship will be awarded for a period of 5 years and may be renewed once, contingent upon continued research productivity and leadership. The Harry and Elsa Jiler American Cancer Society Clinical Research Professor will also be required to be a spokesperson for the American Cancer Society.
The deadline for receipt of applications is October 1, 1997. Applications are furnished by the American Cancer Society after discussion with the Scientific Program Director (Ralph Vogler, MD; 404-329-7542 or rvogler@cancer.org) or the Vice President for Extramural Grants (John Stevens, MD; 404-329-7550 or jstevens@cancer.org) at the American Cancer Society, Inc., 1599 Clifton Road, NE, Atlanta, GA 30329-4251, fax, 404-321-4669.
A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?
